KKR Invests in Precipart to Accelerate Growth

October 24, 2023

KKR has agreed to invest in Precipart, a Swiss contract manufacturer of precision components for the medical device, aerospace and industrial markets. The Laubscher family will retain a significant minority stake; KKR is investing through its Health Care Strategic Growth Fund II to support Precipart's organic growth and M&A-driven expansion. Financial terms were not disclosed.

Targets
Precipart
Industry
Manufacturing
Location
Switzerland
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.